[Comparison of therapeutic effects in severe nocturia: gradual versus immediate drug withdrawal]

Fang-Zheng Tang1, Ya-Lan Liu, Fei-Qiu Wen

  • 1Department of Pediatrics, Second Affiliated Hospital of Jinan University Medical College, Shenzhen, Guangdong 518020, China. annalyc@126.com

Insights

Gradual drug withdrawal after treatment for severe nocturia (bedwetting) in children leads to better long-term outcomes than immediate cessation. This approach improves prognosis for nocturnal enuresis management.

Area of Science:

  • Pediatric Urology
  • Pharmacology
  • Clinical Medicine

Background:

  • Nocturnal enuresis (bedwetting) is a common condition in children.
  • Severe nocturia requires effective management strategies.
  • Understanding optimal drug withdrawal protocols is crucial for sustained treatment success.

Purpose of the Study:

  • To compare the long-term effectiveness of immediate versus gradual drug withdrawal in children with severe nocturia.
  • To evaluate the impact of different drug tapering schedules on enuresis recurrence.

Main Methods:

  • A randomized controlled trial involving 97 children with severe nocturia.
  • Two groups: immediate drug withdrawal (control) and gradual dose tapering (observed) after 12 weeks of treatment.
  • Enuresis frequency was assessed three months post-withdrawal.

Main Results:

  • Both groups achieved over 90% reduction in enuresis during treatment.
  • Significantly higher sustained enuresis reduction (92%) in the gradual withdrawal group compared to the immediate withdrawal group (60%) at three months (p<0.01).
  • No significant differences in adverse effects or medication compliance were observed.

Conclusions:

  • Gradual drug withdrawal schedules appear superior to immediate cessation for managing severe nocturia in children.
  • A phased approach to medication cessation may improve long-term prognosis and reduce relapse rates for nocturnal enuresis.
Abstract

Related Concept Videos

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...